See more : Metallica Minerals Limited (MLMZF) Income Statement Analysis – Financial Results
Complete financial analysis of Elixinol Wellness Limited (EXL.AX) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Elixinol Wellness Limited, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- B2Digital, Incorporated (BTDG) Income Statement Analysis – Financial Results
- Co-Diagnostics, Inc. (CODX) Income Statement Analysis – Financial Results
- Siemens Energy AG (ENR.DE) Income Statement Analysis – Financial Results
- Essence Fastening Systems (Shanghai) Co., Ltd. (301005.SZ) Income Statement Analysis – Financial Results
- Shizuki Electric Company Inc. (6994.T) Income Statement Analysis – Financial Results
Elixinol Wellness Limited (EXL.AX)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.elixinolwellness.com
About Elixinol Wellness Limited
Elixinol Wellness Limited, through its subsidiaries, manufactures and distributes hemp derived nutraceuticals, cosmetics, and food products under the Elixinol and Hemp Foods Australia brands in the Americas, Europe, and Australia. It offers hemp derived cannabidiol and food products, dietary supplements, topicals, and skincare products. The company was formerly known as Elixinol Global Limited and changed its name to Elixinol Wellness Limited in May 2021. The company was incorporated in 2017 and is headquartered in Sydney, Australia.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|
| Revenue | 8.27M | 7.06M | 9.34M | 15.01M | 30.71M | 37.13M | 0.00 |
| Cost of Revenue | 5.00M | 10.32M | 15.59M | 24.59M | 31.46M | 17.18M | 17.00K |
| Gross Profit | 3.27M | -3.27M | -6.26M | -9.58M | -743.00K | 19.96M | -17.00K |
| Gross Profit Ratio | 39.50% | -46.29% | -66.98% | -63.84% | -2.42% | 53.74% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 6.17M | 4.44M | 5.48M | 8.57M | 12.27M | 10.76M | 6.35M |
| Selling & Marketing | 1.82M | 2.29M | 3.68M | 7.17M | 12.82M | 7.41M | 36.00K |
| SG&A | 7.99M | 6.74M | 9.35M | 15.74M | 25.09M | 18.18M | 2.72M |
| Other Expenses | -4.57M | 472.00K | 2.51M | 522.00K | 88.00K | 734.00K | 0.00 |
| Operating Expenses | 3.42M | 6.74M | 9.35M | 15.74M | 25.09M | 20.93M | 2.72M |
| Cost & Expenses | 14.26M | 17.06M | 24.95M | 40.34M | 56.54M | 38.11M | 2.74M |
| Interest Income | 213.00K | 22.00K | 47.00K | 100.00K | 564.00K | 441.00K | 2.00K |
| Interest Expense | 101.00K | 71.00K | 92.00K | 49.00K | 133.00K | 0.00 | 0.00 |
| Depreciation & Amortization | 597.00K | 721.00K | 1.49M | 3.21M | 2.80M | 612.00K | 17.00K |
| EBITDA | -6.81M | -9.28M | -15.51M | -23.36M | -83.50M | 1.08M | -2.72M |
| EBITDA Ratio | -82.31% | -131.55% | -151.20% | -147.33% | -74.99% | -0.40% | 0.00% |
| Operating Income | -5.99M | -10.00M | -15.61M | -25.33M | -25.83M | -978.00K | -2.74M |
| Operating Income Ratio | -72.44% | -141.77% | -167.16% | -168.73% | -84.09% | -2.63% | 0.00% |
| Total Other Income/Expenses | -1.51M | -567.00K | -1.48M | -74.95M | -60.60M | 477.00K | 2.00K |
| Income Before Tax | -7.50M | -10.57M | -17.09M | -99.20M | -86.43M | -497.00K | -2.73M |
| Income Before Tax Ratio | -90.75% | -149.81% | -183.02% | -660.91% | -281.39% | -1.34% | 0.00% |
| Income Tax Expense | 3.00K | 2.00K | -65.00K | 4.20M | -7.54M | 363.00K | -22.00K |
| Net Income | -7.51M | -10.57M | -17.03M | -104.51M | -80.62M | -860.00K | -2.71M |
| Net Income Ratio | -90.78% | -149.84% | -182.32% | -696.24% | -262.50% | -2.32% | 0.00% |
| EPS | -0.01 | -0.03 | -0.04 | -0.45 | -0.41 | -0.01 | -0.02 |
| EPS Diluted | -0.01 | -0.03 | -0.04 | -0.45 | -0.41 | -0.01 | -0.02 |
| Weighted Avg Shares Out | 608.68M | 406.38M | 404.77M | 230.68M | 196.99M | 131.31M | 153.33M |
| Weighted Avg Shares Out (Dil) | 608.68M | 406.38M | 404.77M | 230.68M | 196.99M | 131.31M | 153.33M |
Source: https://incomestatements.info
Category: Stock Reports